🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective is to determine the safety and tolerability of combinati...
Status
Completed
Location
Washington University School of Medicine
Start Date
2010-05
Trial ID
NCT01001143
Treatments Being Tested
Study to assess venetoclax + azacitidine and donor lymphocyte infusion (DLI...
Status
Active Not Recruiting
Location
CHU d'Angers
Start Date
2022-11-23
Trial ID
NCT05226455
Treatments Being Tested
The purpose of this study is to determine the safety of adding Decitabine a...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-07-17
Trial ID
NCT07044544
Treatments Being Tested
The goal of this research study is to test if the combination of a new T ce...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-02-12
Trial ID
NCT07374029
Treatments Being Tested
A multi-center, open-label, dose-finding study of five dose levels of APVO4...
Status
Recruiting
Location
Colorado Blood Cancer Institute
Start Date
2024-10-01
Trial ID
NCT06634394
Treatments Being Tested
Induction treatment (every 3 weeks, total 6 cycles) * Azacitidine D-2, -1,...
Status
Recruiting
Location
81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Start Date
2022-07-01
Trial ID
NCT05230680
Treatments Being Tested
Systemic mastocytosis with an associated hematologic neoplasm (SM-AHN) is a...
Status
Recruiting
Location
Mayo Clinic - Arizona
Start Date
2024-03-13
Trial ID
NCT06327685
Treatments Being Tested
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate Safet...
Status
Completed
Location
University of Michigan
Start Date
2020-07-06
Trial ID
NCT04139434
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of nivolum...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-10-03
Trial ID
NCT03628209
Treatments Being Tested
The combination of TMZ and DAC may effect dual modulation of DNA repair gen...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2008-06
Trial ID
NCT00715793
Treatments Being Tested